Liquid metals (LMs) possess tremendous potential applications in flexible electronic devices, heat flow management, and smart actuators. Splitting the bulk LMs into microspheres is of great significance to fabricate free-standing and microscale LM-based functional materials and devices. However, it is difficult to disperse the bulk LMs into microspheres because of their large surface tension and high density. In this work, the capillary-based microfluidic chip is employed to continuously and automatically generate LM microspheres in a large scale. The capillary-based microfluidic fabrication is universally applicable in ionic aqueous solution, hydrophobic solution, and the polymeric aqueous solution. The precise size control of LM microspheres can be easily realized by the co-flowing configuration in the microchannels. The coefficient of size variation of monodispersed LM microspheres can be controlled to as low as 0.47%. The free-standing LM microspheres can be used as functional microelectrodes within a wide temperature range from −19.8 to 20 °C and to fabricate tunable integrated circuits with different output powers. Most importantly, the LM microspheres exhibit photothermal property, which is used to make the optical sensor with linear response and to conduct the solar energy harvesting. The capillary-based microfluidic fabrication of LM microspheres provides a facile and templated methodology for processing bulk LMs into microscale units. The LM microspheres with excellent electrical conductivity and photothermal property hold great promise for the development of miniature soft electronics, light-driven actuators, and energy conversion medium.

No abstract

No abstract

In December 2019, coronavirus disease 2019 became a pandemic affecting more than 200 countries and territories. Millions of lives are still affected because of mandatory quarantines, which hamstring economies and induce panic. Immunology plays a major role in the modern field of medicine, especially against virulent infectious diseases. In this field, neutralizing antibodies are heavily studied because they reflect the level of infection and individuals' immune status, which are essential when considering resumption of work, flight travel, and border entry control. More importantly, it also allows evaluating the antiviral vaccine efficacy as vaccines are still known for being the ultimate intervention method to inhibit the rapid spread of virulent infectious diseases. In this Review, we first introduce the host immune response after the infection of SARS-CoV-2 and discuss the latest results using conventional immunoassays. Next, as an enabling platform for detection with sufficient sensitivity while saving analysis time and sample size, the progress of microfluidic-based immunoassays is discussed and compared based on surface modification, microfluidic kinetics, signal output, signal amplification, sample matrix, and the detection of anti-SARS-CoV-2 antibodies. Based on the overall comparison, this Review concludes by proposing the future integration of visual quantitative signals on microfluidic devices as a more suitable approach for general use and large-scale surveillance.

3D Confined blue phase liquid crystal microcapsules exhibit a widened BP temperature range, thermotropic color library and reversible surface-switch mode.

No abstract

Various COVID-19 vaccines are currently deployed, but their immunization varies and decays with time. Antibody level is a potent correlate to immune protection, but its quantitation relies on intensive laboratory techniques. Here, we report a decentralized, instrument-free microfluidic device that directly visualizes SARS-CoV-2 antibody levels. Magnetic microparticles (MMPs) and polystyrene microparticles (PMPs) can bind to SARS-CoV-2 antibodies simultaneously. In a microfluidic chip, this binding reduces the incidence of free PMPs escaping from magnetic separation and shortens PMP accumulation length at a particle dam. This visual quantitative result enables use in either sensitive mode [limit of detection (LOD): 13.3 ng/ml; sample-to-answer time: 70 min] or rapid mode (LOD: 57.8 ng/ml; sample-to-answer time: 20 min) and closely agrees with the gold standard enzyme-linked immunosorbent assay. Trials on 91 vaccinees revealed higher antibody levels in mRNA vaccinees than in inactivated vaccinees and their decay in 45 days, demonstrating the need for point-of-care devices to monitor immune protection.

No abstract